Neurimmune is a biopharmaceutical company translating human immune memory into transformative antibody therapeutics. Neurimmune develops drug candidates for CNS and related protein aggregation diseases including Alzheimer’s disease, amyotrophic lateral sclerosis and ATTR cardiomyopathy.

Location
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2006
  • Number of employees in Switzerland
    50-149
Key business

You may also be interested in